FDA Associate Commissioner Approves of Testing Drugs on Foster Children

Prescription Drugs

A debate over giving psychotropic drugs to foster children erupted last year after a 7-year-old boy who was heavily medicated while in foster care took his own life. Since that time, the state of Florida has taken a closer look at the use of psychotropic medication in state foster care. In response to one suggestion that foster children should not be used for testing potentially dangerous psychotropic drugs, Jill Hartzler, an associate Food and Drug Administration commissioner, argued that Florida should not bar foster children from being used for psychotropic drug testing because the benefits can outweigh the risks. Who associate commissioner Hartzler thinks ultimately benefits in this benefit/risk balancing analysis is unclear. However, the benefit cannot be intended for the foster children who may be used like guinea pigs or their parents who are helpless to prevent total strangers from subjecting their children to potentially dangerous drug testing.

Richard Wexler with the National Coalition for Child Protection Reform commented, “I would love to ask Associate Commissioner Hartzler if she’d care to let a total stranger decide if her children should be enrolled in a trial for a potentially dangerous drug.”

 


Read the rest of the article: Lyons: Government is Daring to Keep Kids on Drugs

NOTE: Clicking on the link above opens a web site outside of www.heritagedefense.org, where you will encounter content and images which may be inappropriate and which are not endorsed by Heritage Defense.


Help us find important news! If you see a story relevant to the mission of Heritage Defense, please go to our contact page and send us a link. Thanks!

We have you covered. Join our mailing list and we will send you any relevant information pertaining to your state, as well as up to date news as it happens.

Please re-word. A poet-laureate I am not.

LAW AND POLICY

Spotlight on Washington

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.